Zhejiang Tianyu Pharmaceutical Co., Ltd. (SHE:300702)

Market Cap	8.35B
Revenue (ttm)	2.70B
Net Income (ttm)	101.60M
Shares Out	343.93M
EPS (ttm)	0.29
PE Ratio	83.50
Forward PE	33.02
Dividend	0.05 (0.21%)
Ex-Dividend Date	Jun 6, 2025

Volume	1,578,800
Average Volume	8,119,335
Open	22.63
Previous Close	24.27
Day's Range	22.63 - 24.95
52-Week Range	13.55 - 27.20
Beta	0.55
RSI	52.44
Earnings Date	Aug 28, 2025

About SHE:300702

Zhejiang Tianyu Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical intermediates and APIs in China and internationally. The company offers pharmaceutical intermediates and APIs of cardiovascular, anti-diabetic, anti-atherosclerosis, anticoagulant, and anti-asthmatic series. It provides fine chemicals and CDMO services. Zhejiang Tianyu Pharmaceutical Co., Ltd. was founded in 1993 and is based in Taizhou, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 4,532
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300702

Financial Performance

In 2024, SHE:300702's revenue was 2.63 billion, an increase of 4.10% compared to the previous year's 2.53 billion. Earnings were 55.94 million, an increase of 104.45%.